Shop

Wegovy® (Injections)

From $1,550.00 every month
Clinician eligibility review

Complete a health assessment before checkout

A licensed clinician must review your health information to confirm whether this treatment is appropriate for you.

  • Answer health questions
  • Clinician reviews eligibility
  • Continue after approval
An account is required to save and securely submit your answers.
Categories: , , SKU: IMM-WEGOVY-INJECTIONS

(semaglutide)

From $1,550/mo*

Activates GLP-1 receptors, the gut hormone that signals appetite and satiety, supporting long-term weight loss.

*Billed quarterly with a three-month commitment paid up front.

HSA/FSAReimbursable where eligible

Founded by REG3NProactive longevity framework

No insurance requiredAccess care without insurance

Fast, discreet shippingPrivate delivery to your door

Licensed U.S. pharmaciesFulfilled by licensed pharmacies

Physician follow-upOngoing clinician support

$0 membership feesPay only after approval

WHY WEGOVY®

Clinical trials demonstrated substantial weight loss with Wegovy®

STEP 1

Trial In the STEP 1 trial of nearly 2,000 adults with obesity, Wegovy® produced an average 15% body weight reduction (approximately 34 lbs) versus 2.4% with placebo over 16 months. STEP 1 Trial

Source: Wilding et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," New England Journal of Medicine (2021) — the

STEP 1

Trial 83% lost at least 5% of body weight, 69% lost at least 10%, 50% lost at least 15%, and 33% lost at least 20%. STEP 1 Trial

Source: Wilding et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," New England Journal of Medicine (2021) — the

Published study facts

1Trial
60weeks
2021publication year

STEP 1

Trial Weight loss began within the first month and continued steadily for approximately 60 weeks. STEP 1 Trial

Source: Wilding et al., "Once-Weekly Semaglutide in Adults with Overweight or Obesity," New England Journal of Medicine (2021) — the

Charts and graphics are illustrative representations intended to communicate published research findings and the known pharmacologic properties of the referenced medication. Visualizations may simplify, normalize, or model study data for educational purposes and should not be interpreted as guarantees of individual clinical outcomes or expected results.

HOW WEGOVY® WORKS

Reduces appetite.

Sustains weight loss. Wegovy® (semaglutide) mimics GLP-1, a natural hormone released by the gut after eating that signals fullness to the brain.

Wegovy® (Injections)

 

Feel fuller for longer

After eating, the gut releases a hormone called GLP-1 that tells the brain it's time to stop eating. Wegovy® mimics that hormone, but with a structure designed to last days instead of minutes. It activates the same receptors in the brain that regulate hunger and fullness, producing a stronger, more sustained sense of satiety.

 

Sustains weight loss

As appetite decreases naturally, body weight drops meaningfully over time — an average of about 15% in clinical trials among adults without diabetes. That weight loss is accompanied by improvements in blood pressure, blood sugar, waist circumference, and markers of inflammation.

 

Reduces cravings

Wegovy® also slows how quickly food leaves the stomach, so meals feel satisfying for longer and blood sugar rises more gradually after eating. At the same time, it acts on brain pathways that reduce food cravings.

Step 1

Medical intake

Answer a guided set of questions covering your medical history, current medications, goals, and treatment preferences.

A few minutes

Step 2

Doctor review

A U.S.-licensed, board-certified physician reviews your intake and recommends a medication, if appropriate.*

Within 72 hours

Step 3

Fast shipping

Approved medications ship directly to your door in discreet packaging.

2-5 business days

Step 4

Unlimited messaging

Your doctor is available via chat any time for additional support. Video consults available. The same prescription framework as REG3N's medical team. *Some states may require a synchronous audio and/or video consultation prior to a prescription being approved.

Up to 12 months

 

Proactive care

Doctor-led treatment plans designed around your goals. No wait lists. No insurance required.

 

Transparent pricing

No membership fees, no hidden costs. You pay only after a doctor prescribes treatment.

 

Board-certified doctors

Access to specialist physicians, licensed in your state. Unlimited messaging for up to 12 months.

 

Curated by longevity experts

Every protocol is built by medical experts, based on longevity research from REG3N's science team.

What is Wegovy®?

Wegovy® is a GLP-1 receptor agonist that is FDA-approved for chronic weight management as well as to improve blood sugar control in people with type 2 diabetes. Providers also prescribe it off-label within a longevity framework.

How do you take Wegovy®?

Wegovy® is prescribed as either a once-a-week injection or a daily oral tablet. Follow the dosage instructions from your doctor.

What are the side effects of Wegovy®?

Common side effects include nausea, loose stools, and stomach discomfort, particularly in the early weeks. These should settle as your body adjusts. Contact your doctor if side effects are persistent or bothersome.

Who shouldn’t take Wegovy®?

Wegovy® is not recommended for people with a personal or family history of medullary thyroid carcinoma or MEN 2, or for those with severe gastroparesis. Extra caution applies to patients with a prior serious allergic reaction to semaglutide. Your doctor will review your medical history before prescribing.

Disclaimer: This page is intended for educational purposes only and is not intended to provide medical advice, diagnosis or treatment. Medication eligibility and prescriptions are determined solely by licensed medical providers based on clinical appropriateness. Not all individuals will qualify for medication-based treatment. Always consult a licensed healthcare professional before beginning any wellness program.

Activates GLP-1 receptors, the gut hormone that signals appetite and satiety, supporting long-term weight loss.